Heparin-induced thrombocytopenia: Clinical manifestations and management strategies

American Journal of Medicine

Volumn 118, Issue 8 SUPPL., 2005, Pages 21-30

  Menajovsky, L Bernardo ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Deep vein thrombosis; Direct thrombin inhibitors; Heparin induced thrombocytopenia type II; Low molecular weight heparin; Pulmonary embolism; Unfractionated heparin

Indexed keywords

ARGATROBAN; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADRENAL HEMORRHAGE; AORTA OCCLUSION; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DIAGNOSTIC TEST; HEART INFARCTION; HUMAN; LUNG EMBOLISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTOPENIA;

EID: 23944524771     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.06.005     Document Type: Conference Paper

References (40)

1. Barcelona R. Type II heparin-induced thrombocytopenia: new treatment options. Cleveland Clinic Center for Continuing Education Pharmacotherapy Update. 2001;4. Cleveland Clinic Web site. Available at: http://www. clevelandclinicmeded.com/medical_info/pharmacy/septoct2001/thrombocytopenia.htm. Accessed July 23, 2004.
2. Royal College of Pathologists of Australasia (RCPA) Manual, version 4.0, updated March 12 2004. Heparin-induced thrombocytopenia (HIT). Royal College of Pathologists of Australasia Web site. Available at: http://www.rcpamanual.edu. au/sections/clinicalproblem.asp?s=25&i=301. Accessed August 4, 2004.
3. Riley RS. Heparin-induced thrombocytopenia (HIT): frequently asked questions. Virginia Commonwealth University Web site. Available at: http://www.pathology.vcu.edu/clinical/HIT_FAQ.pdf. Accessed July 23, 2004.
4. J.M. Walenga, W.P. Jeske, M.M. Prechel Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs Semin Thromb Hemost 30 suppl 1 2004 69 80
5. T.E. Warkentin, B.H. Chong, A. Greinacher Heparin-induced thrombocytopenia: towards consensus J Thromb Haemost 79 1998 1 7
6. Wallis DE, Warkentin TE. Understanding heparin-induced thrombocytopenia: historical and clinical perspectives [PowerPoint presentation]. CoagInfo.com: The Coagulation Information Source Web site. Available at: http://coaginfo.com/ files/ss5/understanding_Heparin_induced_thrombocytopenia.ppt. Accessed August 6, 2004.
7. Trespalacios F. Grand rounds: heparin-induced thrombocytopenia [PowerPoint presentation]. Walter Reed Army Medical Hospital Web site. Available at: http://www.wramc.amedd.army.mil/departments/medicine/Nephrology/education/ Lectures/HIT-2_files/frame.htm. Accessed July 23, 2004.
8. B.E. Lewis, D.E. Wallis, F. Leya Argatroban-915 Investigators Argatroban anticoagulation in patients with heparin-induced thrombocytopenia Arch Intern Med 163 2003 1849 1856
9. T.E. Warkentin Clinical presentation of heparin-induced thrombocytopenia Semin Hematol 35 suppl 5 1998 9 16 discussion 35-36
10. D.L. DeEugenio, N.J. Ruggiero, L.J. Thomson, L.B. Menajovsky, J.H. Herman Early-onset heparin-induced thrombocytopenia after a 165-day heparin-free interval: Case report and review of the literature Pharmacotherapy 25 2005 615 619
11. N. Lubenow, R. Kempf, A. Eichner Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin Chest 122 2002 37 42
12. W.E. Dager, R.H. White Pharmacotherapy of heparin-induced thrombocytopenia Expert Opin Pharmacother 4 2003 919 940
13. T.E. Warkentin, J.G. Kelton Delayed-onset heparin-induced thrombocytopenia and thrombosis Ann Intern Med 135 2001 502 506
14. T.E. Warkentin, L.J. Elavathil, C.P. Hayward The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia Ann Intern Med 127 1997 804 812
15. A. Greinacher, T.E. Warkentin Treatment of heparin-induced thrombocytopenia: an overview T.E. Warkentin A. Greinacher Heparin-Induced Thrombocytopenia 3rd ed 2004 Marcel Dekker, Inc New York 335 370
16. E. Lindhoff-Last, B. Wenning, M. Stein Risk factors and long-term follow-up of patients with the immune type of heparin-induced thrombocytopenia Clin Appl Thromb Hemost 8 2002 347 352
17. J.L. Laster, W.K. Nichols, D. Silver Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies Arch Intern Med 149 1989 2285 2287
18. S.A. Spinler, W. Dager Overview of heparin-induced thrombocytopenia Am J Health Syst Pharm. 60 suppl 5 2003 S5 S11
19. V. Fuster, M. Verstraete Hemostasis, Thrombosis, Fibrinolysis, and Cardiovascular Disease E. Braunwald Heart Disease: A Textbook of Vascular Medicine. 5th ed. 1997 WB Saunders Philadelphia, PA 1809 1842
20. B.H. Chong Heparin-induced thrombocytopenia Aust N Z J Med 22 1992 145 152
21. T.E. Warkentin, R.S. Roberts, J. Hirsh An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients Arch Intern Med 163 2003 2518 2524
22. Y. Gruel, C. Pouplard, P. Nguyen French Heparin-Induced Thrombocytopenia Study Group Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia Br J Haematol 121 2003 786 792
23. L. Rice, W.K. Attisha, A. Drexler Delayed-onset heparin-induced thrombocytopenia Ann Intern Med 136 2002 210 215
24. Levine RL. Heparin-induced thrombocytopenia: challenges of diagnosis and treatment. Physicians Weekly Online Surgery Edition [serial online]; July 19, 2004;1. Available at: http://www.physiciansweekly.com/pc.asp?edition= 2&issueid=151&questionid=153. Accessed July 23, 2004.
25. T.E. Warkentin, J.G. Kelton A 14-year study of heparin-induced thrombocytopenia Am J Med 101 1996 502 507
26. Greinacher A, Lubenow N. Heparin-induced thrombocytopenia. Orphanet Encyclopedia [publication online]; December 2003. Orphanet Web site. Available at: http://www.orpha.net/data/patho/GB/uk-HIT.pdf. Accessed April 6, 2005.
27. J. Amiral, F. Bridey, M. Wolf Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases Thromb Haemost 73 1995 21 28
28. 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia Am J Clin Pathol 104 1995 648 654
29. B.H. Chong, J. Burgess, F. Ismail The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia Thromb Haemost 69 1995 344 350
30. S.G. Pauker, R.I. Kopelman Interpreting hoofbeats: can Bayes help clear the haze? N Engl J Med 327 1992 1009 1013
31. T.E. Warkentin Heparin-induced thrombocytopenia Circulation 110 2004 454 458
32. T.J. Fagan Nomogram for Bayes's theorem N Engl J Med 293 1975 257
33. R. Jaeschke, G. Guyatt, D. Sackett The Evidence-Based Medicine Working Group Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 271 1994 703 707
34. A.K. Gupta, M.J. Kovacs, D.N. Sauder Heparin-induced thrombocytopenia Ann Pharmacother 32 1998 55 59
35. T.E. Warkentin Heparin-induced thrombocytopenia Curr Hematol Rep 1 2002 63 72
36. D.E. Wallis, R. Quintos, W. Wehrmacher Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia Chest 116 1999 1333 1338
37. A.F. Srinivasan, L. Rice, J.R. Bartholomew Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia Arch Intern Med 164 2004 66 70
38. A. Greinacher, U. Janssens, G. Berg Heparin-Associated Thrombocytopenia Study (HAT) investigators. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia Circulation 100 1999 587 593
39. K.W. Mahaffey, B.E. Lewis, N.M. Wildermann ATBAT Investigators The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results J Invasive Cardiol 15 2003 611 616
40. A. Greinacher, H. Völpel, U. Janssens Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study Circulation 99 1999 73 80